Colorectal cancer

British Medical Journal

Volumn 335, Issue 7622, 2007, Pages 715-718

  Ballinger, Anne B ^a   Anggiansah, Clive ^a  

^a HOMERTON UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CARCINOGENESIS; COLONOSCOPY; COLORECTAL CANCER; HUMAN; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SYMPTOMATOLOGY; COLORECTAL TUMOR; MASS SCREENING; ORGANIZATION AND MANAGEMENT; PATIENT REFERRAL; PROGNOSIS; RISK FACTOR;

COLORECTAL NEOPLASMS; HUMANS; MASS SCREENING; PROGNOSIS; REFERRAL AND CONSULTATION; RISK FACTORS;

EID: 35248830118     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.39321.527384.BE     Document Type: Review

References (27)

1. Boyle P, Ferlay J, Cancer incidence and mortality in Europe 2004. Ann Oncol 2005;16:481-8.
2. Office for National Statistics. Cancer statistics registrations: registrations of cancer diagnosed in 2004, England. www.statistics.gov.
3. Quinn M, Babb P, Brock A, Kirby L, Jones J. Cancer trends in England and Wales 1950-1999. Vol SMPS No 66, 2001. www.statistics.gov.
4. Arnold CN, Goel A, Blum HE, Boland CR. Molecular pathogenesis of colorectal cancer. Cancer 2005;104:2035-47.
5. Winawer S, Fletcher R, Rex D, Bond J, Burt R, Ferrucci J, et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale - update based on new evidence. Gastroenterology 2003;124:544-60.
6. Dunlop MG. Guidance on large bowel surveillance for people with two first degree relatives with colorectal cancer or one first degree relative diagnosed with colorectal cancer under 45 years. Gut 2002;51(suppl V):17-20.
7. Rockey DC, Cello JP. Evaluation of the gastrointestinal tract in patients with iron-deficiency anemia. N Engl J Med 1993;329:1691-5.
8. Goddard AF, James MW, McIntyre AS, Scott BB. Guidelines for the management of iron deficiency anaemia. London: British Society of Gastroenterology, 2005. www.bsg.org.uk.
9. Rockey RC, Paulson E, Niedzwiecki D, Davis W, Bosworth HB, Sanders L, et al. Analysis of air contrast barium enema, computed tomographic colonography, and colonoscopy: prospective comparison. Lancet 2005;365:305-11.
10. Mulhall BP, Veerappan GR, Jackson JL. Meta-analysis: computed tomographic colonography. Ann Intern Med 2005;142:635-50.
11. Van Rijn JC, Reitsma JB, Stoker J, Bossuyt PM, van Deventer SJ, Dekker E. Polyp miss rate determined by tandem colonoscopy: a systematic review. Am J Gastroenterol 2006;101:343-50.
12. McDonald S, Lyall P, Israel L, Coates R, Frizelle F. Why barium enemas fail to identify colorectal cancers. Aust N Z J Surg 2001;71:627-8.
13. Rex DK, Rahmani EY, Haseman JH, Lemmel GT, Kaster S, Buckley JS. Relative sensitivity of colonoscopy and barium enema for detection of colorectal cancer in clinical practice. Gastroenterology 1997;112:17-23.
14. Leslie A, Virjee JP. Detection of colorectal carcinoma on double contrast barium enema when double reporting is routinely performed: an audit of current practice. Clin Radiol 2002;57:184-7.
15. Gluecker TM, Johnson CD, Harmsen WS, Offord KP, Harris AM, Wilson LA, et al. Colorectal cancer screening with CT colonography, colonoscopy, and double-contrast barium enema examination: prospective assessment of patient perceptions and preferences. Radiology 2003;227:378-84.
16. Bosworth HB, Rockey DC, Paulson EK, Niedzwiecki D, Davis W, Sanders LL, et al. Prospective comparison of patient experience with colon imaging tests. Am J Med 2006;119:791-9.
17. Ganeshan A, Upponi S, Uberoi R, D'Costa H, Picking C, Bungay H. Minimal-preparation CT colon in detection of colonic cancer, the Oxford experience. Age Ageing 2007;36:48-52.
18. Kealey SM, Dodd JD, MacEneaney PM, Gibney RG, Malone DE. Minimal preparation computed tomography instead of barium enema/colonoscopy for suspected colon cancer in frail elderly patients: an outcome analysis study. Clin Radiol 2004;59:44-52.
19. Gill S, Blackstock AW, Goldberg RM. Colorectal cancer. Mayo Clin Proc 2007;82:114-29.
20. O'Connell JB, Maggard MA, Ko CY. Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. J Natl Cancer Inst 2004;96:1420-5.
21. Niv Y, Lev-El M, Fraser G, Abuksis G, Tamir A. Protective effect of faecal occult blood test screening for colorectal cancer: worse prognosis for screening refusers. Gut 2002;50:33-7.
22. Coleman MP, Gatta G, Verdecchia A, Estève J, Sant M, Storm H, et al. EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century. Ann Oncol 2003;14:v128-46.
23. Gatta G, Capocaccia R, Sant M, Bell CMJ, Coebergh JWW, Damhuis RAM, et al. Understanding variations in survival for colorectal cancer in Europe: a EUROCARE high resolution study. Gut 2000;47:533-8.
24. Collins PD, Mpofu C, Watson AJ, Rhodes JM. Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease. Cochrane Database Syst Rev 2006;(2):CD000279.
25. Hewitson P, Glasziou P, Irwig L, Towler B, Watson E. Screening for colorectal cancer using the faecal occult blood test, Hemoccult. Cochrane Database Syst Rev 2007;(1):CD001216.
26. NHS bowel cancer screening programme. www.cancerscreening.nhs.uk/bowel/ index.html.
27. Pignone M, Saha S, Hoerger T, Mandelblatt J. Cost-effectiveness analyses of colorectal cancer screening. Ann Intern Med 2002;137:96-104.